Regional differences in recipient waitlist timeand pre- and post-transplant mortality after the 2006 united network for organ sharing policy changes in the donor heart allocation algorithm

JACC: Heart Failure

Volumn 2, Issue 2, 2014, Pages 166-177

  Schulze, P Christian ^a   Kitada, Shuichi ^a   Clerkin, Kevin ^a   Jin, Zhezhen ^b   Mancini, Donna M ^a  

^a Department of Medicine Division of Cardiology College of Physicians and Surgeons Columbia University Medical Center ^*  (United States)

^b Division of Biostatistics Mailman School of Public Health Columbia University Medical Center ^*  (United States)

Author keywords

Heart transplantation; United Network of organ sharing; Ventricular assist device

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR MORTALITY; CHANGE MANAGEMENT; CONTROLLED STUDY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE POLICY; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS; REGIONALIZATION; RESOURCE ALLOCATION; SURVIVAL RATE; ALGORITHM; EPIDEMIOLOGY; HEART ASSIST DEVICE; HEART FAILURE; HOSPITAL ADMISSION; MIDDLE AGED; MORTALITY; ORGANIZATION AND MANAGEMENT; POSTOPERATIVE CARE; PREOPERATIVE CARE; TRANSPLANTATION; UNITED STATES; UTILIZATION; DEVICE THERAPY; DONOR HEART ALLOCATION; GEOGRAPHIC DISTRIBUTION; GRAFT RECIPIENT; HEALTH CARE DISTRIBUTION; HOSPITAL MANAGEMENT; UNITED NETWORK FOR ORGAN SHARING POLICY; WAITLIST TIME;

ALGORITHMS; FEMALE; HEALTH POLICY; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; RESOURCE ALLOCATION; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 84897547719     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.11.005     Document Type: Article

References (17)

1. Go A.S., Mozaffarian D., Roger V.L., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-245.
2. Ammar K.A., Jacobsen S.J., Mahoney D.W., et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation 2007, 115:1563-1570.
3. Stehlik J., Edwards L.B., Kucheryavaya A.Y., et al. The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. JHeart Lung Transplant 2012, 31:1052-1064.
4. OPTN data as of January 18, 2013. Available at: Accessed January 23,2013. http://optn.transplant.hrsa.gov/latestData/advancedData.asp.
5. Singh T.P., Almond C.S., Taylor D.O., Graham D.A. Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts. Circ Heart Fail 2012, 5:249-258.
6. Nativi J.N., Kfoury A.G., Myrick C., et al. Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. JHeart Lung Transplant 2010, 29:235-239.
7. Wever-Pinzon O., Drakos S.G., Kfoury A.G., et al. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?. Circulation 2013, 127:452-462.
8. Kirklin J.K., Naftel D.C., Kormos R.L., et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. JHeart Lung Transplant 2013, 32:141-156.
9. Uriel N., Jorde U.P., Woo Pak S., et al. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. JHeart Lung Transplant 2013, 32:188-195.
10. Kamdar F., John R., Eckman P., Colvin-Adams M., Shumway S.J., Liao K. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. JThorac Cardiovasc Surg 2013, 145:575-581.
11. Russo M.J., Hong K.N., Davies R.R., et al. Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. JThorac Cardiovasc Surg 2009, 138:1425-1432. e1-3.
12. Osaki S., Edwards N.M., Johnson M.R., et al. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience. JHeart Lung Transplant 2009, 28:591-597.
13. Miller L.W., Guglin M. Patient selection for ventricular assist devices: a moving target. JAm Coll Cardiol 2013, 61:1209-1221.
14. Miller L.W., Guglin M., Rogers J. Cost of ventricular assist devices: can we afford the progress?. Circulation 2013, 127:743-748.
15. Mulloy D.P., Bhamidipati C.M., Stone M.L., Ailawadi G., Kron I.L., Kern J.A. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. JThorac Cardiovasc Surg 2013, 145:566-573. discussion 573-4.
16. Moreno S.G., Novielli N., Cooper N.J. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. JHeart Lung Transplant 2012, 31:450-458.
17. Dardas T., Mokadam N.A., Pagani F., Aaronson K., Levy W.C. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time. JAm Coll Cardiol 2012, 60:36-43.